U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07518654) titled 'Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Tran... Read More
U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07516600) titled 'Optimizing Weblinks Used in Digital Vaccination Invitations to Raise Trust and Booking Inte... Read More
U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07518563) titled 'Neural Synchronization During Gesture Production and Comprehension in Individuals With Apha... Read More
U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07517783) titled '"Comparison of Clip-Based and Clipless Laparoscopic Gallbladder Surgery in Controlling Blee... Read More
U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07516964) titled 'SLIT ABS: Study on Patients With Autoimmune Podocytopathy' on April 01. Brief Summary: Nep... Read More
Kokrajhar, April 9 -- Chief Executive Member (CEM) of the Bodoland Territorial Council (BTC), Hagrama Mohilary, on Thursday cast his vote in the ongoing Assam elections and expressed confidence in the... Read More
Dhaka, April 9 -- e-Islami Secretary General Mia Golam Parwar on Thursday accused the BNP of eliciting a political crisis in the country, by what he described as "refusing to accept the verdict of 70 ... Read More
Nepal, April 9 -- ''To ruin a woman's life, all it takes is assassinating her character.'' These were National Assembly Vice-President Leela Kumari Bhandari's first public statement upon assuming off... Read More
India, April 9 -- Actor and Tamilaga Vettri Kazhagam (TVK) chief Vijay seems to be running into one hurdle after another, with the latest one being that portions of his film are being leaked online. E... Read More
New Delhi, April 9 -- What comes after success? For Virat Kohli, and a new, self-driven India - the answer isn't just celebration. It's continuation. In a bold power-play where Icon meets Icon, Johnn... Read More